{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:52:28Z","timestamp":1791827548401,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10072-026-09363-z","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:06:19Z","timestamp":1788242779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Smoking and disability outcomes in multiple sclerosis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1115-4610","authenticated-orcid":false,"given":"Bassel","family":"Alrabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Alghzawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alwaleed Emad","family":"Alshakhshir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Bandak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan I.","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseel","family":"Badwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Z.","family":"Obeidat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"9363_CR1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L et al (2020) Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler 26:1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841","journal-title":"Mult Scler"},{"key":"9363_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson T, Barcellos LF, Alfredsson L (2017) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol 13:25\u201336. https:\/\/doi.org\/10.1038\/nrneurol.2016.187","journal-title":"Nat Rev Neurol"},{"key":"9363_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1055\/s-0036-1579693","volume":"36","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Munger KL (2016) Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update. Semin Neurol 36:103\u2013114. https:\/\/doi.org\/10.1055\/s-0036-1579693","journal-title":"Semin Neurol"},{"key":"9363_CR4","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"KL Munger","year":"2006","unstructured":"Munger KL, Levin LI, Hollis BW et al (2006) Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis. JAMA 296:2832\u20132838. https:\/\/doi.org\/10.1001\/jama.296.23.2832","journal-title":"JAMA"},{"key":"9363_CR5","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1177\/1352458512436596","volume":"18","author":"AK Hedstr\u00f6m","year":"2012","unstructured":"Hedstr\u00f6m AK, Olsson T, Alfredsson L (2012) High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 18:1334\u20131336. https:\/\/doi.org\/10.1177\/1352458512436596","journal-title":"Mult Scler"},{"key":"9363_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1756285611425694","volume":"5","author":"DM Wingerchuk","year":"2012","unstructured":"Wingerchuk DM (2012) Smoking: effects on multiple sclerosis susceptibility and disease progression. Ther Adv Neurol Disord 5:13\u201322. https:\/\/doi.org\/10.1177\/1756285611425694","journal-title":"Ther Adv Neurol Disord"},{"key":"9363_CR7","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0140-6736(15)60264-1","volume":"385","author":"V Bilano","year":"2015","unstructured":"Bilano V, Gilmour S, Moffiet T et al (2015) Global trends and projections for tobacco use, 1990\u20132025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control. Lancet (London England) 385:966\u2013976. https:\/\/doi.org\/10.1016\/S0140-6736(15)60264-1","journal-title":"Lancet (London England)"},{"key":"9363_CR8","doi-asserted-by":"publisher","unstructured":"Arnson Y, Shoenfeld Y, Amital H (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34. https:\/\/doi.org\/10.1016\/j.jaut.2009.12.003. :J258-65","DOI":"10.1016\/j.jaut.2009.12.003"},{"key":"9363_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/brain\/awq371","volume":"134","author":"AK Hedstr\u00f6m","year":"2011","unstructured":"Hedstr\u00f6m AK, Sundqvist E, B\u00e4\u00e4rnhielm M et al (2011) Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain 134:653\u2013664. https:\/\/doi.org\/10.1093\/brain\/awq371","journal-title":"Brain"},{"key":"9363_CR10","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1136\/ard.2007.075192","volume":"67","author":"D Makrygiannakis","year":"2008","unstructured":"Makrygiannakis D, Hermansson M, Ulfgren A-K et al (2008) Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 67:1488\u20131492. https:\/\/doi.org\/10.1136\/ard.2007.075192","journal-title":"Ann Rheum Dis"},{"key":"9363_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10654-013-9853-4","volume":"28","author":"AK Hedstr\u00f6m","year":"2013","unstructured":"Hedstr\u00f6m AK, Hillert J, Olsson T, Alfredsson L (2013) Smoking and multiple sclerosis susceptibility. Eur J Epidemiol 28:867\u2013874. https:\/\/doi.org\/10.1007\/s10654-013-9853-4","journal-title":"Eur J Epidemiol"},{"key":"9363_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/EDE.0000000000000089","volume":"25","author":"FBS Briggs","year":"2014","unstructured":"Briggs FBS, Acuna B, Shen L et al (2014) Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variants. Epidemiology 25:605\u2013614. https:\/\/doi.org\/10.1097\/EDE.0000000000000089","journal-title":"Epidemiology"},{"key":"9363_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/ane.12916","volume":"138","author":"P Heydarpour","year":"2018","unstructured":"Heydarpour P, Manouchehrinia A, Beiki O et al (2018) Smoking and worsening disability in multiple sclerosis: A meta-analysis. Acta Neurol Scand 138:62\u201369. https:\/\/doi.org\/10.1111\/ane.12916","journal-title":"Acta Neurol Scand"},{"key":"9363_CR14","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"9363_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603\u2013605. https:\/\/doi.org\/10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"9363_CR16","doi-asserted-by":"publisher","first-page":"e011458","DOI":"10.1136\/bmjopen-2016-011458","volume":"6","author":"MJ Downes","year":"2016","unstructured":"Downes MJ, Brennan ML, Williams HC, Dean RS (2016) Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open 6:e011458. https:\/\/doi.org\/10.1136\/bmjopen-2016-011458","journal-title":"BMJ Open"},{"key":"9363_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.msard.2018.08.016","volume":"25","author":"R Aktan","year":"2018","unstructured":"Aktan R, Ozalevli S, Ozakbas S (2018) Effects of cigarette smoking on respiratory problems and functional levels in multiple sclerosis patients. Mult Scler Relat Disord 25:271\u2013275. https:\/\/doi.org\/10.1016\/j.msard.2018.08.016","journal-title":"Mult Scler Relat Disord"},{"key":"9363_CR18","doi-asserted-by":"publisher","unstructured":"Farren BS (2018) Briggs1,*, Douglas D. Gunzler2, Daniel Ontaneda3 and RAM Smokers with MS have greater decrements in quality of life and disability than non-smokers. Mult Scler 176:139\u2013148. https:\/\/doi.org\/10.1177\/1352458516685169.Smokers","DOI":"10.1177\/1352458516685169.Smokers"},{"key":"9363_CR19","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1212\/01.wnl.0000277658.78381.db","volume":"69","author":"M Koch","year":"2007","unstructured":"Koch M, Van Harten A, Uyttenboogaart M, De Keyser J (2007) Cigarette smoking and progression in multiple sclerosis. Neurology 69:1515\u20131520. https:\/\/doi.org\/10.1212\/01.wnl.0000277658.78381.db","journal-title":"Neurology"},{"key":"9363_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/NXI.0000000000000260","volume":"3","author":"S Kvistad","year":"2016","unstructured":"Kvistad S, Myhr KM, Holm\u00f8y T et al (2016) No association of tobacco use and disease activity in multiple sclerosis. Neurol Neuroimmunol NeuroInflammation 3:1\u20135. https:\/\/doi.org\/10.1212\/NXI.0000000000000260","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"key":"9363_CR21","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1093\/brain\/awt139","volume":"136","author":"A Manouchehrinia","year":"2013","unstructured":"Manouchehrinia A, Tench CR, Maxted J et al (2013) Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain 136:2298\u20132304. https:\/\/doi.org\/10.1093\/brain\/awt139","journal-title":"Brain"},{"key":"9363_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00415-009-0120-2","volume":"256","author":"F Pittas","year":"2009","unstructured":"Pittas F, Ponsonby AL, Van Der Mei IAF et al (2009) Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol 256:577\u2013585. https:\/\/doi.org\/10.1007\/s00415-009-0120-2","journal-title":"J Neurol"},{"key":"9363_CR23","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/j.1468-1331.2009.02603.x","volume":"16","author":"A Sena","year":"2009","unstructured":"Sena A, Couderc R, Ferret-Sena V et al (2009) Apolipoprotein e polymorphism interacts with cigarette smoking in progression of multiple sclerosis. Eur J Neurol 16:832\u2013837. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02603.x","journal-title":"Eur J Neurol"},{"key":"9363_CR24","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1177\/1352458508093615","volume":"14","author":"P Sundstr\u00f6m","year":"2008","unstructured":"Sundstr\u00f6m P, Nystr\u00f6m L (2008) Smoking worsens the prognosis in multiple sclerosis. Mult Scler 14:1031\u20131035. https:\/\/doi.org\/10.1177\/1352458508093615","journal-title":"Mult Scler"},{"key":"9363_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1212\/WNL.0b013e3181b2a706","volume":"73","author":"R Zivadinov","year":"2009","unstructured":"Zivadinov R, Weinstock-Guttman B, Hashmi K et al (2009) Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology 73:504\u2013510. https:\/\/doi.org\/10.1212\/WNL.0b013e3181b2a706","journal-title":"Neurology"},{"key":"9363_CR26","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1212\/01.wnl.0000484266.87397.05","volume":"86","author":"A Sena","year":"2016","unstructured":"Sena A, Capela C, Ferret-Sena V et al (2016) No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT. Neurology 86:2026. https:\/\/doi.org\/10.1212\/01.wnl.0000484266.87397.05","journal-title":"Neurology"},{"key":"9363_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.7224\/1537-2073.2023-053","volume":"26","author":"EC Contentti","year":"2024","unstructured":"Contentti EC, Rojas JI, Giachello S et al (2024) Smoking and Health-Related Quality of Life in Patients With Multiple Sclerosis From Latin America. Int J MS Care 26:187\u2013193. https:\/\/doi.org\/10.7224\/1537-2073.2023-053","journal-title":"Int J MS Care"},{"key":"9363_CR28","doi-asserted-by":"publisher","first-page":"107846","DOI":"10.1016\/j.clineuro.2023.107846","volume":"232","author":"M Hosseini","year":"2023","unstructured":"Hosseini M, Haghighatzadeh M, Hassanpour R et al (2023) The effects of different types of smoking on recovery from attack in hospitalized multiple sclerosis patients. Clin Neurol Neurosurg 232:107846. https:\/\/doi.org\/10.1016\/j.clineuro.2023.107846","journal-title":"Clin Neurol Neurosurg"},{"key":"9363_CR29","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/ene.13262","volume":"24","author":"O Javizian","year":"2017","unstructured":"Javizian O, Metz LM, Deighton S, Koch MW (2017) Smoking does not influence disability accumulation in primary progressive multiple sclerosis. Eur J Neurol 24:624\u2013630. https:\/\/doi.org\/10.1111\/ene.13262","journal-title":"Eur J Neurol"},{"key":"9363_CR30","doi-asserted-by":"publisher","unstructured":"Johansson S, Skjerb\u00e6k AG, N\u00f8rgaard M et al (2021) Associations between fatigue impact and lifestyle factors in people with multiple sclerosis \u2013 The Danish MS hospitals rehabilitation study. Mult Scler Relat Disord 50. https:\/\/doi.org\/10.1016\/j.msard.2021.102799","DOI":"10.1016\/j.msard.2021.102799"},{"key":"9363_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.arcmed.2017.03.002","volume":"48","author":"WC Paz-Ballesteros","year":"2017","unstructured":"Paz-Ballesteros WC, Monterrubio-Flores EA, de Jes\u00fas Flores-Rivera J et al (2017) Cigarette Smoking, Alcohol Consumption and Overweight in Multiple Sclerosis: Disability Progression. Arch Med Res 48:113\u2013120. https:\/\/doi.org\/10.1016\/j.arcmed.2017.03.002","journal-title":"Arch Med Res"},{"key":"9363_CR32","doi-asserted-by":"publisher","first-page":"101872","DOI":"10.1016\/j.msard.2019.101872","volume":"38","author":"A Sakoda","year":"2020","unstructured":"Sakoda A, Matsushita T, Nakamura Y et al (2020) Environmental risk factors for multiple sclerosis in Japanese people. Mult Scler Relat Disord 38:101872. https:\/\/doi.org\/10.1016\/j.msard.2019.101872","journal-title":"Mult Scler Relat Disord"},{"key":"9363_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/jnnp-2022-330848","volume":"94","author":"J Wu","year":"2023","unstructured":"Wu J, Olsson T, Hillert J et al (2023) Influence of oral tobacco versus smoking on multiple sclerosis disease activity and progression. J Neurol Neurosurg Psychiatry 94:589\u2013596. https:\/\/doi.org\/10.1136\/jnnp-2022-330848","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9363_CR34","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1001\/archneurol.2009.122","volume":"66","author":"BC Healy","year":"2009","unstructured":"Healy BC, Ali EN, Guttmann CRG et al (2009) Smoking and disease progression in multiple sclerosis. Arch Neurol 66:858\u2013864. https:\/\/doi.org\/10.1001\/archneurol.2009.122","journal-title":"Arch Neurol"},{"key":"9363_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, Bittner S, Zivadinov R et al (2024) Multiple sclerosis. Lancet 403:183\u2013202. https:\/\/doi.org\/10.1016\/S0140-6736(23)01473-3","journal-title":"Lancet"},{"key":"9363_CR36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00415-025-13248-0","volume":"272","author":"BK Vitturi","year":"2025","unstructured":"Vitturi BK, Cellerino M, Boccia D et al (2025) Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysis. J Neurol 272:513. https:\/\/doi.org\/10.1007\/s00415-025-13248-0","journal-title":"J Neurol"},{"key":"9363_CR37","doi-asserted-by":"publisher","unstructured":"Kotlyarov S (2023) The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24108725","DOI":"10.3390\/ijms24108725"},{"key":"9363_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-03075-8","volume":"15","author":"ZO Khudhur","year":"2025","unstructured":"Khudhur ZO, Smail SW, Awla HK et al (2025) The effects of heavy smoking on oxidative stress, inflammatory biomarkers, vascular dysfunction, and hematological indices. Sci Rep 15:1\u201315. https:\/\/doi.org\/10.1038\/s41598-025-03075-8","journal-title":"Sci Rep"},{"key":"9363_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jsps.2010.02.002","volume":"18","author":"MM Alsalahy","year":"2010","unstructured":"Alsalahy MM, Nasser HS, Hashem MM, Elsayed SM (2010) Effect of tobacco smoking on tissue protein citrullination and disease progression in patients with rheumatoid arthritis. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc 18:75\u201380. https:\/\/doi.org\/10.1016\/j.jsps.2010.02.002","journal-title":"Saudi Pharm J SPJ Off Publ Saudi Pharm Soc"},{"key":"9363_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/JIR.S12059","volume":"3","author":"A Shirani","year":"2010","unstructured":"Shirani A, Tremlett H (2010) The effect of smoking on the symptoms and progression of multiple sclerosis: a review. J Inflamm Res 3:115\u2013126. https:\/\/doi.org\/10.2147\/JIR.S12059","journal-title":"J Inflamm Res"},{"key":"9363_CR41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.7224\/1537-2073.2021-069","volume":"25","author":"CEP van Munster","year":"2023","unstructured":"van Munster CEP, Jessica B, Steinheimer S et al (2023) Assessment of Multiple Aspects of Upper Extremity Function Independent From Ambulation in Patients With Multiple Sclerosis. Int J MS Care 25:226\u2013232. https:\/\/doi.org\/10.7224\/1537-2073.2021-069","journal-title":"Int J MS Care"},{"key":"9363_CR42","doi-asserted-by":"publisher","first-page":"103144","DOI":"10.1016\/j.msard.2021.103144","volume":"54","author":"M Cohen","year":"2021","unstructured":"Cohen M, Bresch S, Thommel Rocchi O et al (2021) Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability. Mult Scler Relat Disord 54:103144. https:\/\/doi.org\/10.1016\/j.msard.2021.103144","journal-title":"Mult Scler Relat Disord"},{"key":"9363_CR43","doi-asserted-by":"publisher","first-page":"100602","DOI":"10.1016\/j.ensci.2025.100602","volume":"42","author":"A Arteaga-Noriega","year":"2026","unstructured":"Arteaga-Noriega A, Zapata-Berruecos J, Guti\u00e9rrez-Vargas J et al (2026) Factors associated with the progression of disability (EDSS) among MS patients. eNeurologicalSci 42:100602. https:\/\/doi.org\/10.1016\/j.ensci.2025.100602","journal-title":"eNeurologicalSci"},{"key":"9363_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.7224\/1537-2073.2020-114","volume":"24","author":"B Weinstock-Guttman","year":"2022","unstructured":"Weinstock-Guttman B, Sormani MP, Repovic P (2022) Predicting Long-term Disability in Multiple Sclerosis: A Narrative Review of Current Evidence and Future Directions. Int J MS Care 24:184\u2013188. https:\/\/doi.org\/10.7224\/1537-2073.2020-114","journal-title":"Int J MS Care"},{"key":"9363_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0166-4328(00)00206-0","volume":"113","author":"L Fratiglioni","year":"2000","unstructured":"Fratiglioni L, Wang HX (2000) Smoking and Parkinson\u2019s and Alzheimer\u2019s disease: review of the epidemiological studies. Behav Brain Res 113:117\u2013120. https:\/\/doi.org\/10.1016\/s0166-4328(00)00206-0","journal-title":"Behav Brain Res"},{"key":"9363_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/0271678X241270415","volume":"45","author":"MG Ewees","year":"2025","unstructured":"Ewees MG, El-Mahdy MA, Hannawi Y, Zweier JL (2025) Tobacco cigarette smoking induces cerebrovascular dysfunction followed by oxidative neuronal injury with the onset of cognitive impairment. J Cereb blood flow Metab Off J Int Soc Cereb Blood Flow Metab 45:48\u201365. https:\/\/doi.org\/10.1177\/0271678X241270415","journal-title":"J Cereb blood flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"9363_CR47","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1161\/01.STR.0000100165.36466.95","volume":"34","author":"T Kurth","year":"2003","unstructured":"Kurth T, Kase CS, Berger K et al (2003) Smoking and Risk of Hemorrhagic Stroke in Women. Stroke 34:2792\u20132795. https:\/\/doi.org\/10.1161\/01.STR.0000100165.36466.95","journal-title":"Stroke"},{"key":"9363_CR48","doi-asserted-by":"publisher","first-page":"1484164","DOI":"10.3389\/fpubh.2024.1484164","volume":"12","author":"I Cicekli","year":"2024","unstructured":"Cicekli I, Gokce Eskin S (2024) High prevalence and co-occurrence of modifiable risk factors for non-communicable diseases among university students: a cross-sectional study. Front public Heal 12:1484164. https:\/\/doi.org\/10.3389\/fpubh.2024.1484164","journal-title":"Front public Heal"},{"key":"9363_CR49","doi-asserted-by":"publisher","first-page":"32773","DOI":"10.1007\/s11356-021-17905-5","volume":"29","author":"L Yuan","year":"2022","unstructured":"Yuan L, Ni J (2022) The association between tobacco smoke exposure and vitamin D levels among US general population, 2001\u20132014: temporal variation and inequalities in population susceptibility. Environ Sci Pollut Res Int 29:32773\u201332787. https:\/\/doi.org\/10.1007\/s11356-021-17905-5","journal-title":"Environ Sci Pollut Res Int"},{"key":"9363_CR50","doi-asserted-by":"publisher","unstructured":"Schreiner T-G, Genes T-M (2021) Obesity and Multiple Sclerosis-A Multifaceted Association. J Clin Med 10. https:\/\/doi.org\/10.3390\/jcm10122689","DOI":"10.3390\/jcm10122689"},{"key":"9363_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","volume":"7","author":"MB Sintzel","year":"2018","unstructured":"Sintzel MB, Rametta M, Reder AT (2018) Vitamin D and Multiple Sclerosis: A Comprehensive Review. Neurol Ther 7:59\u201385. https:\/\/doi.org\/10.1007\/s40120-017-0086-4","journal-title":"Neurol Ther"},{"key":"9363_CR52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/1352458517694088","volume":"24","author":"K Wesnes","year":"2018","unstructured":"Wesnes K, Myhr K-M, Riise T et al (2018) Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study. Mult Scler 24:150\u2013157. https:\/\/doi.org\/10.1177\/1352458517694088","journal-title":"Mult Scler"},{"key":"9363_CR53","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1086\/516736","volume":"80","author":"H Kallberg","year":"2007","unstructured":"Kallberg H, Padyukov L, Plenge RM et al (2007) Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 80:867\u2013875. https:\/\/doi.org\/10.1086\/516736","journal-title":"Am J Hum Genet"},{"key":"9363_CR54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1053\/pcad.2003.11","volume":"45","author":"XL Wang","year":"2003","unstructured":"Wang XL, Raveendran M, Wang J (2003) Genetic influence on cigarette-induced cardiovascular disease. Prog Cardiovasc Dis 45:361\u2013382. https:\/\/doi.org\/10.1053\/pcad.2003.11","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09363-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09363-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09363-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:34:12Z","timestamp":1791826452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09363-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9363"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09363-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethical approval and consent to participate was needed.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ahmed Z. Obeidat: received honoraria for speaking from Alexion, Amgen, Biogen, Bristol Myers Squibb, EMD Serono, Sanofi-Genzyme, TG Therapeutics and consulting fees for advisory boards or steering committees from Alexion, Amgen, AstraZeneca, Banner Life Sciences, Biogen, Bristol Myers Squibb, EMD Serono, Genentech, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics. Received honoraria from Medscape, MJH Life Sciences, and WebMD for educational and editorial activities. The other authors report no conflict of Interest.","order":2,"name":"Ethics","label":"Conflicts of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"751"}}